Bal Pharma Limited (BALPHARMA) Q2 FY27 Financial Results: PAT ₹291.19 Cr & Revenue ₹1,252.08 Cr

13 August 2026 · NSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

Metric	Value
Revenue	₹1,252.08 Cr
Net Profit (PAT)	₹291.19 Cr

📢 Key Event

Bal Pharma reports Q3 FY2026 revenue of ₹1,252.08 crore and net profit of ₹291.19 crore; IEPF claim deadline October 30, 2026

🔄 What Changed

Net profit of ₹291.19 crore for Q3 FY2026; IEPF claim deadline set for October 30, 2026

🔮 What's Next

None

💡 Investor Takeaway

Shareholders must claim unclaimed dividends by October 30, 2026 to avoid transfer to IEPF Authority.

Bal Pharma announced unaudited Q3 FY2026 results showing total revenue of ₹1,252.08 crores and net profit of [amount context mismatch] crores for the quarter ended June 30, 2026, alongside a regulatory IEPF notice requiring shareholder claims by October 30, 2026 for unclaimed dividends since FY 2018-19.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BALPHARMA ✨ Ask AI About This

About Bal Pharma Limited (BALPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹177.95 CrP/E: 24.6ROE: 8.8%ROCE: 10.0%Div Yield: 1.07%

View full BALPHARMA stock details →

📡 Get AI alerts when BALPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BALPHARMA — Free

💡 Ask AI about this filing

"What is the Q3 FY2026 revenue growth YoY?""How does net profit compare to previous quarter?""What is the IEPF claim process for shareholders?"

Ask AI Free →

📊 More BALPHARMA filings

Announcement — 25 September 2026Bal Pharma Ltd announced the closure of its trading window effective October 1, 2026, until 48 hours...
🟡 Board Meeting — 25 September 2026Bal Pharma announced at its September 24, 2026 AGM the re-appointment of Ravindra Kumar Kothari as D...
🟡 Board Meeting — 24 September 2026Bal Pharma held its 39th AGM on September 24, 2026, approving a Rs. 1.20 per share dividend for FY20...
Announcement — 10 September 2026Bal Pharma clarified that recent price volatility in its shares is market-driven with no price-sensi...
🔴 Corporate Action — 7 September 2026Bal Pharma announced the allotment of 10 lakh convertible warrants to promoter Shailesh Siroya at ₹8...

See all BALPHARMA filings →

🔥 Also filed on 13 August 2026

EIFFLEuro India Fresh Foods LimitedCorporate Action APOLLOHOSPApollo Hospitals Enterprise LimitedFinancial Results EIDPARRYEID Parry India LimitedFinancial Results TAJGVKTaj GVK Hotels & Resorts LimitedCorporate Action SIGMAADVSIGMA ADVANCED SYSTEMS LIMITEDFinancial Results INDIQUBEIndiqube Spaces LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BALPHARMA files new disclosures

Track BALPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.